Logo Logo Logo Logo

Immunogenicity Integrated

Scientist at work


Laura Salazar-Fontana, Arno Kromminga and Paul Chamberlain are members of the NDA Advisory Board, part of the NDA Group. NDA Group assists global clients by providing “end-to-end” integrated drug development and regulatory service as required by their projects. The deliverables focus on high quality and are based on input from clinical, scientific, technical and regulatory experts with the goal to bring value through critical feedback to existing plans, qualitative and quantitative analyses, and to further optimize underlying strategies, highlighting challenges and possible solutions in the regulatory route to approval. Through a global network of key-opinion-leaders, the board will also bring knowledge of state-of-art technologies in support of integrated product development and market access.